Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjali Sharathkumar

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Thrombosis and Haemostasis : JTH|May 15, 2022
Recommendations for standardized definitions, clinical assessment, and future research in pediatric clinically unsuspected venous thromboembolism: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasisMarisol Betensky, Ketan Kulkarni, Mattia Rizzi, et al.
Journal of Thrombosis and Haemostasis : JTH|November 2, 2025
Frequency of, and prognostic factors for, residual thrombosis and complete veno-occlusion following anticoagulation for provoked venous thromboembolism in patients <21 years: findings from the Kids-DOTT Multinational TrialRukhmi Bhat, Anjali Sharathkumar, Riten Kumar, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2025
Bone Health Screening in Persons With Bleeding Disorders: A Survey of United States Haemophilia Treatment CentresDivyaswathi Citla-Sridhar, Sanjay Ahuja, Robert Sidonio, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 12, 2022
Associated comorbidities, healthcare utilization & mortality in hospitalized patients with haemophilia in the United States: Contemporary nationally representative estimatesJonathan R Day, Clifford Takemoto, Anjali Sharathkumar, et al.
Blood Vessels, Thrombosis & Hemostasis|August 18, 2025
Risk factors for joint bleeding in severe hemophilia A and B: analysis of the Community Counts longitudinal surveillance cohortMarilyn J Manco-Johnson, Binh Le, Suchitra Acharya, et al.
Blood|November 24, 2025
Platelet defects in patients and mice with Ehlers-Danlos syndromeMariia Kumskova, Gagan D Flora, Manasa K Nayak, et al.
The Lancet. Haematology|December 8, 2020
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trialJacqueline Halton, Leonardo R Brandão, Matteo Luciani, et al.
Clinical Pharmacokinetics|August 23, 2019
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate<sup>®</sup>): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc SubgroupPierre Chelle, Cindy H T Yeung, Stacy E Croteau, et al.
Critical Care Medicine|December 29, 2020
Efficacy of Early Prophylaxis Against Catheter-Associated Thrombosis in Critically Ill Children: A Bayesian Phase 2b Randomized Clinical TrialE Vincent S Faustino, Veronika Shabanova, Leslie J Raffini, et al.
Pediatric Blood & Cancer|May 20, 2024
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendationsKristin A Shimano, Ghadir Sasa, Larisa Broglie, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Haemostasis : JTH|May 15, 2022
Recommendations for standardized definitions, clinical assessment, and future research in pediatric clinically unsuspected venous thromboembolism: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasisMarisol Betensky, Ketan Kulkarni, Mattia Rizzi, et al.
Journal of Thrombosis and Haemostasis : JTH|November 2, 2025
Frequency of, and prognostic factors for, residual thrombosis and complete veno-occlusion following anticoagulation for provoked venous thromboembolism in patients <21 years: findings from the Kids-DOTT Multinational TrialRukhmi Bhat, Anjali Sharathkumar, Riten Kumar, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2025
Bone Health Screening in Persons With Bleeding Disorders: A Survey of United States Haemophilia Treatment CentresDivyaswathi Citla-Sridhar, Sanjay Ahuja, Robert Sidonio, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 12, 2022
Associated comorbidities, healthcare utilization & mortality in hospitalized patients with haemophilia in the United States: Contemporary nationally representative estimatesJonathan R Day, Clifford Takemoto, Anjali Sharathkumar, et al.
Blood Vessels, Thrombosis & Hemostasis|August 18, 2025
Risk factors for joint bleeding in severe hemophilia A and B: analysis of the Community Counts longitudinal surveillance cohortMarilyn J Manco-Johnson, Binh Le, Suchitra Acharya, et al.
Blood|November 24, 2025
Platelet defects in patients and mice with Ehlers-Danlos syndromeMariia Kumskova, Gagan D Flora, Manasa K Nayak, et al.
The Lancet. Haematology|December 8, 2020
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trialJacqueline Halton, Leonardo R Brandão, Matteo Luciani, et al.
Clinical Pharmacokinetics|August 23, 2019
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate<sup>®</sup>): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc SubgroupPierre Chelle, Cindy H T Yeung, Stacy E Croteau, et al.
Critical Care Medicine|December 29, 2020
Efficacy of Early Prophylaxis Against Catheter-Associated Thrombosis in Critically Ill Children: A Bayesian Phase 2b Randomized Clinical TrialE Vincent S Faustino, Veronika Shabanova, Leslie J Raffini, et al.
Pediatric Blood & Cancer|May 20, 2024
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendationsKristin A Shimano, Ghadir Sasa, Larisa Broglie, et al.
Pageof 5